Skip to main content

Table 3 Sensitivity analysis by sequential omission of each individual study

From: Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis

Meta-analysis estimates, given the named study is omitted
Study omitted Hazard ratio for overall survival (95% CI) Hazard ratio for progression-free survival (95% CI)
Porrata et al. (2012a) [51] 2.82 (1.61, 4.93) 2.18 (1.33, 3.59)
Porrata et al. (2012b) [52] 2.25 (1.47, 3.43) 2.06 (1.29, 3.29)
Koh et al. (2015) [53] 2.60 (1.57, 4.31)
Tadmor et al. (2015) [54] 3.12 (2.22, 4.37) 2.66 (1.82, 3.88)
Simon et al. (2016) [55] 2.48 (1.53, 4.01) 1.86 (1.34, 2.57)
Vassilakopoulos et al. (2016) [56] 2.66 (1.53, 4.63)
Jakovic et al. (2016) [57] 2.82 (1.61, 4.94)
Romano et al. (2018) [58] 2.37 (1.45, 3.90)